Collplant Biotechnologies Ltd

자세한 내용은 Collplant Biotechnologies Ltd 회사

CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

회사 정보

종목 코드 CLGN

회사 이름Collplant Biotechnologies Ltd

상장일Sep 01, 1993

CEOMr. Eran Rotem, CPA

직원 수57

유형Ordinary Share

회계 연도 종료Sep 01

주소4 Oppenheimer Street

도시REHOVOT

증권 거래소NASDAQ Global Market Consolidated

국가Israel

우편 번호7670104

전화972732325600

웹사이트https://www.collplant.com

종목 코드 CLGN

상장일Sep 01, 1993

CEOMr. Eran Rotem, CPA

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Yehiel Tal

Chief Executive Officer

31.14K

--

Dr. Philippe David Bensimon

Vice President - Regulatory Affairs and Quality Assurance

2.00K

--

Dr. Nadav Orr

Vice President - Research & Development

--

Dr. Elan Penn, Ph.D.

Independent Director

--

Dr. Roger J. Pomerantz, M.D.

Independent Chairman of the Board

--

Dr. Oded Shoseyov, Ph.D.

Founder, Chief Scientist

--

Dr. Gili Hart

Independent Director

--

Mr. Joseph Zarzewsky

Independent Director

--

Mr. Eran Rotem, CPA

Deputy Chief Executive Officer, Chief Financial Officer

--

Dr. Abraham (Avri) Havron, Ph.D.

Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Mr. Yehiel Tal

Chief Executive Officer

31.14K

--

Dr. Philippe David Bensimon

Vice President - Regulatory Affairs and Quality Assurance

2.00K

--

Dr. Nadav Orr

Vice President - Research & Development

--

Dr. Elan Penn, Ph.D.

Independent Director

--

Dr. Roger J. Pomerantz, M.D.

Independent Chairman of the Board

--

Dr. Oded Shoseyov, Ph.D.

Founder, Chief Scientist

--

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2024

FY2024Q2

FY2023

FY2023Q2

FY2022

FY2022Q2

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Revenues from the sales of goods

515.00K

0.00%

지역별USD

이름

수익

비율

United States

484.00K

93.98%

Israel

31.00K

6.02%

Europe

0.00

0.00%

Canada

0.00

0.00%

사업별

지역별

사업별USD

이름

수익

비율

Revenues from the sales of goods

515.00K

0.00%

주식 보유 통계

마지막 업데이트: Sat, May 17

주주

주주 유형

주주

비율

Sagy (Ami)

15.28%

Loewenbaum (George Walter)

8.97%

St. Denis J. Villere & Company, LLC

4.30%

Pinnacle Associates Ltd.

3.85%

Evans (Hugh M)

2.97%

Other

64.63%

주주

비율

Sagy (Ami)

15.28%

Loewenbaum (George Walter)

8.97%

St. Denis J. Villere & Company, LLC

4.30%

Pinnacle Associates Ltd.

3.85%

Evans (Hugh M)

2.97%

Other

64.63%

주주 유형

주주

비율

Individual Investor

29.91%

Investment Advisor

7.11%

Investment Advisor/Hedge Fund

4.77%

Hedge Fund

1.06%

Family Office

0.13%

Research Firm

0.11%

Other

56.90%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

40

5.46M

42.96%

+129.16K

2025Q1

43

5.89M

47.00%

-12.15K

2024Q4

45

6.34M

55.34%

-153.24K

2024Q3

47

6.23M

54.37%

+33.99K

2024Q2

47

6.08M

53.11%

-244.01K

2024Q1

47

6.01M

52.48%

-307.66K

2023Q4

51

6.09M

53.32%

-149.24K

2023Q3

56

6.34M

55.87%

-109.84K

2023Q2

58

6.40M

56.58%

+145.86K

2023Q1

60

5.97M

52.82%

-340.05K

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Sagy (Ami)

1.94M

15.28%

--

Mar 15, 2025

Loewenbaum (George Walter)

1.14M

8.97%

+86.46K

+8.20%

Dec 31, 2024

St. Denis J. Villere & Company, LLC

483.87K

3.81%

--

Mar 31, 2025

Pinnacle Associates Ltd.

489.19K

3.85%

-500.00

-0.10%

Mar 31, 2025

Evans (Hugh M)

377.43K

2.97%

-1.00

-0.00%

Mar 15, 2025

Roumell Asset Management, L.L.C.

276.43K

2.17%

-38.86K

-12.32%

Jun 30, 2024

Loewenbaum (Lilian Shaw)

275.74K

2.17%

+70.09K

+34.08%

Dec 31, 2024

AMH Equity, Ltd.

125.00K

0.98%

+8.50K

+7.30%

Mar 31, 2025

Brown Advisory

111.20K

0.87%

-8.27K

-6.92%

Mar 31, 2025

Benjamin F. Edwards & Company, Inc.

39.76K

0.31%

-10.69K

-21.19%

Jun 30, 2024

2.280USD

Collplant Biotechnologies Ltd

2.280

개요

회사

금융